文献速递关节外科

全髋与全膝关节置换术后急性肾脏病:发生率及相关因素

Acute Kidney Disease After Total Hip and Knee Arthroplasty: Incidence and Associated Factors.
PubMed 文献 · J Arthroplasty · 2017-03-16

该研究纳入2010年1月至2016年5月间898例全髋或全膝关节置换病例,术后急性肾脏病发生率为6.8%(n=61)。围术期使用血管紧张素受体阻滞剂或血管紧张素转换酶抑制剂(OR=2.09,P=.030)、体质指数增加(每10 kg/m² OR=1.58,P=.014)及围术期使用万古霉素(OR=1.91,P=.021)与术后急性肾脏病风险增加相关。

要点

  • 全髋或全膝关节置换术后急性肾脏病发生率为6.8%。
  • 围术期使用ARBs或ACEi与术后急性肾脏病风险增加相关(OR=2.09,P=.030)。
  • 体质指数增加(每10 kg/m² OR=1.58)和围术期万古霉素使用(OR=1.91)与风险增加相关。

核心结论

  • 全髋或全膝关节置换术后急性肾脏病发生率为6.8%。
  • 围术期使用ARBs/ACEi、围术期使用万古霉素及体质指数增加与术后急性肾脏病风险增加相关。

研究设计与样本

  • 回顾性识别2010年1月至2016年5月间连续1000例全髋或全膝关节置换病例(860例独特患者,含翻修)。
  • 排除79例既往肾功能不全及23例数据不完整病例后,最终纳入898例,其中女性492例、男性406例,平均年龄58.1岁(范围14-93岁)。
  • 采用风险、损伤、衰竭、肾功能丧失和终末期肾病(RIFLE)标准及血清肌酐值判定急性肾脏病状态,并使用多元逻辑回归模型识别术后急性肾脏病危险因素。

主要发现

  • 术后急性肾脏病总体发生率为6.8%(n=61)。
  • 围术期使用血管紧张素受体阻滞剂或血管紧张素转换酶抑制剂与术后急性肾脏病风险增加相关(OR=2.09;P=.030)。
  • 体质指数增加与术后急性肾脏病风险增加相关(每10 kg/m² OR=1.58;P=.014)。
  • 围术期使用万古霉素与术后急性肾脏病风险增加相关(OR=1.91;P=.021)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The development of acute kidney disease (AKD) following total joint arthroplasty has not been well characterized in the literature. We sought to calculate the incidence and identify risk factors associated with postoperative AKD for patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA). METHODS: A total of 1000 consecutive cases (860 unique patients, including revisions) of TKA or THA performed between January 2010 and May 2016 were identified. Seventy-nine cases were excluded due to pre-existing kidney dysfunction and 23 additional cases were excluded due to incomplete data, resulting in 898 cases included in the study. There were 492 females and 406 males with a mean age of 58.1 years (range, 14-93 years). The Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease criteria and serum creatinine values were used to determine AKD status. Multiple logistic regression modeling was used to identify postoperative AKD risk factors. RESULTS: Overall incidence of postoperative AKD was 6.8% (n = 61). Use of perioperative angiotensin receptor blocker (ARBs) or angiotensin-converting enzyme inhibitors (ACEi) (odds ratio [OR] = 2.09; P = .030), increasing body mass index (BMI) (OR = 1.58 per 10 kg/m2; P = .014), and use of vancomycin perioperatively (OR = 1.91; P = .021) were associated with increased odds of development of postoperative AKD. CONCLUSION: A 6.8% incidence rate of postoperative AKD was noted in patients undergoing TKA or THA. Perioperative use of ARBs/ACEi, perioperative vancomycin use, and increased BMI were associated with increased odds of postoperative AKD.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Jiang EX, Gogineni HC, Mayerson JL, et al. Acute Kidney Disease After Total Hip and Knee Arthroplasty: Incidence and Associated Factors. J Arthroplasty. 2017. PMID: 28392132. doi:10.1016/j.arth.2017.03.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。